Recently, DCLK1 has been identified as a cancer stem cell (CSC) marker [7, 8] and was overexpressed in many types of cancer, including colorectal cancer, pancreatic cancer, esophageal cancer, renal clear cell carcinoma (RCC), and breast cancer [9–14]. This evidence concerns the gene DCLK1 and breast carcinoma.